Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry.
about
Multi-channel cell co-culture for drug development based on glass microfluidic chip-mass spectrometry coupled platform.Personalized Proteomics: The Future of Precision Medicine.Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.Quantitation of human peptides and proteins via MS: review of analytically validated assays.Applications of low-flow LC-SRM for the analysis of large molecules in pharmaceutical R&D.CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC/MS/MS.Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS.Practical applications of integrated microfluidics for peptide quantification.Practical immunoaffinity-enrichment LC-MS for measuring protein kinetics of low-abundance proteinsSimultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry.The application of a new microfluidic device for the simultaneous identification and quantitation of midazolam metabolites obtained from a single micro-litre of chimeric mice blood.SRM-based measurements of proprotein convertase subtilisin/kexin type 9 and lipoprotein(a) kinetics in nonhuman primate serum.
P2860
Q36107621-0B95A91C-B7C7-4722-A79C-2C3C50E4D4BAQ37426540-D69AE3CE-FCB3-4A1E-AD1E-57263C1A9C6AQ37603961-310D037F-BF57-4A0B-9D00-D5B88A14FD09Q38243345-00A9344E-38B7-4BF8-B126-57FE95D04645Q38243346-AF0BB604-E862-4431-9CFC-A3AFACA1D284Q38373582-CF94257F-83F4-4564-ADAC-45DEDCAF0CCCQ38627350-95CB8B9D-13FE-4E13-957C-1AD3D1A31AB4Q39896235-CD76AA5E-99B0-4027-8AF6-86B6382A048EQ40988523-4A5A62FC-7D77-4449-9E65-8438ACB01463Q41781616-F6379E06-249E-4155-BA5E-66B5AB9F7A0AQ45830031-9DF1302E-C899-447B-B3E5-C6593B019BD4Q47880031-33C10D9B-E9F5-4E2B-9426-65D4BFA90932Q51305608-12C2131B-FBBA-48A1-9DDF-A94083AA608C
P2860
Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measurement of apo
@nl
Measurement of apo(a) kinetics ...... with tandem mass spectrometry.
@en
type
label
Measurement of apo
@nl
Measurement of apo(a) kinetics ...... with tandem mass spectrometry.
@en
prefLabel
Measurement of apo
@nl
Measurement of apo(a) kinetics ...... with tandem mass spectrometry.
@en
P2093
P2860
P356
P1476
Measurement of apo(a) kinetics ...... with tandem mass spectrometry.
@en
P2093
Brian K Hubbard
Daniel J Rader
David E Gutstein
Gissette Reyes-Soffer
Haihong Zhou
Henry N Ginsberg
John A Wagner
John S Millar
Jose Castro-Perez
Michael E Lassman
P2860
P304
P356
10.1002/RCM.6572
P577
2013-06-01T00:00:00Z